Cross-practice Team Advises on Arrowhead Research’s Acquisition of Roche RNA Assets

In The News
October 28, 2011
Jonathan M. Zorn
Megan Bisk , Jennifer A. Rikoski

A cross-practice Ropes & Gray team advised Arrowhead Research Corporation in its acquisition of RNA therapeutics assets from Roche, announced on Oct. 24. As a result of the transaction, Arrowhead will have an array of additional delivery technologies that complement its existing delivery platforms, access to the three primary siRNA formats, and the infrastructure and team necessary to create new RNAi therapeutics and drive large industry partnerships.

The Ropes & Gray team included benefits partner Jonathan Zorn (Boston); and associates Megan Bisk (Boston), Elizabeth Norman (Boston), and Jennifer Rikoski (Boston).